Investor Intelligence: Comp Tables

Comp Tables as of March 16, 2020: Market swoon compresses multiples

By Michael Regan, Equity Research Analyst
and Craig Behnke, , Equity Research Analyst

These comp tables provide a benchmark for private investors to evaluate existing and future investments and a way for companies to judge their own valuations for current and future capital raises, as well as a menu for public investors to peruse.

Read Article


Comp tables as of Feb. 10: Estimates and multiples drop

By MJBizDaily Staff

Average trading multiples for U.S.-focused operators are 2.5X 2020 sales and 12.5X 2020 EBITDA, down from last week’s 2.6X and 13.4X, respectively. The big changes are that consensus revenue expectations dropped for Harvest Health & Recreation (-8% for 2020 and 13% for 2021) and Curaleaf (-2% for 2020 and -8% for 2021). Canada-focused operators still […]

Read Article